A novel two-step procedure to expand cardiac Sca-1+ cells clonally.
about
Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applicationsHypoxic preconditioning improves survival of cardiac progenitor cells: role of stromal cell derived factor-1α-CXCR4 axisIntra-myocardial injection of both growth factors and heart derived Sca-1+/CD31- cells attenuates post-MI LV remodeling more than does cell transplantation alone: neither intervention enhances functionally significant cardiomyocyte regenerationValidation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue.Sca-1+ cardiosphere-derived cells are enriched for Isl1-expressing cardiac precursors and improve cardiac function after myocardial injuryAngiotensin II promotes differentiation of mouse c-kit-positive cardiac stem cells into pacemaker-like cells.Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation.Infrared fluorescent protein 1.4 genetic labeling tracks engrafted cardiac progenitor cells in mouse ischemic heartsOverexpression of SDF-1α enhanced migration and engraftment of cardiac stem cells and reduced infarcted size via CXCR4/PI3K pathway.Human cardiospheres as a source of multipotent stem and progenitor cells.Genetic modification of stem cells for transplantation.G-CSF-based stem cell therapy for the heart--unresolved issues part B: Stem cells, engraftment, transdifferentiation, and bioengineering.Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury.Stem cells in the heart: what's the buzz all about?--Part 1: preclinical considerationsHypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression.Cellular cardiomyoplasty: what have we learned?Developmental and regenerative biology of multipotent cardiovascular progenitor cells.Autologous cell therapy for cardiac repair.Enhancement of Anti-Hypoxic Activity and Differentiation of Cardiac Stem Cells by Supernatant Fluids from Cultured Macrophages that Phagocytized Dead Mesenchymal Stem Cells.Stem cell therapy for heart failure: the science and current progress.Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies.Cellular and molecular characterization of human cardiac stem cells reveals key features essential for their function and safety.The role of notch 1 activation in cardiosphere derived cell differentiation.Activated macrophages as a feeder layer for growth of resident cardiac progenitor cells.Human cardiospheres are a source of stem cells with cardiomyogenic potential.Identification of stem cells after transplantation.Assessing in vitro stem-cell function and tracking engraftment of stem cells in ischaemic hearts by using novel iRFP gene labelling.Functional ion channels in mouse cardiac c-kit(+) cells.Preconditioning of Cardiosphere-Derived Cells With Hypoxia or Prolyl-4-Hydroxylase Inhibitors Increases Stemness and Decreases Reliance on Oxidative Metabolism.Suxiao Jiuxin pill promotes exosome secretion from mouse cardiac mesenchymal stem cells in vitro.
P2860
Q27025973-0626C7A7-C72B-4036-9FDA-4DF90952C3A2Q27302080-1A3EEA59-F15C-425E-B1DE-BDD4DFF6C0EFQ27338187-351CC0E9-0ACD-4E84-9CA5-D2B94D91CCF2Q33506639-98DEBA23-FB77-4DEE-AFEB-F747E965F82CQ34137691-54B9EDA1-D54C-4869-A4DD-9515F5B6416CQ35201693-5E2CD616-AC9E-48DD-8E8E-F8B68A2365EDQ35234806-07125D9A-6A47-4135-AAD7-ABDA914D97EEQ35377949-841376EC-B9BC-48C2-89D4-4004F762C215Q36227062-8D3088C1-3A37-4E6D-851B-9EBAD246D28CQ36882814-365F96FE-F5F1-47C9-90C5-2EE447742466Q37010620-789124BF-D56A-48C6-9234-C1077613C96BQ37018479-FF52F717-4CBA-4BD6-8422-443D2BF4BE2CQ37066520-F199B0C2-006A-44F8-9426-0915271FE44EQ37153062-814EC18E-2EB4-40E3-90C2-0FB00F073464Q37372976-765847A1-B542-4F01-88FD-0980C68CDFB9Q37514676-704395D3-DE13-465E-A11F-0094940BE612Q37835598-5D4EC870-6699-4E38-9904-907A157947F0Q37837891-9E55EA7A-D034-4E40-8012-7F086CFA61DEQ38838857-C94A6EE3-8DC1-43EF-93C0-A1C6963BF2AEQ40097837-5247EE30-57CF-4ECF-9FD8-A0D232E06406Q41061514-72392656-3B71-43D1-97FE-A67BE5BC07D2Q41619434-4621505A-F18C-4E88-A917-8E9945DCA84BQ41827110-A14F251E-A09A-4255-BFC7-D6D5945B61EBQ41902675-DE615570-701E-4E2F-9961-5268043F14FBQ42260552-5047A955-6839-4500-8D43-7D7234932DDFQ42287557-6340019D-1929-4286-A56A-74A18B84A6B1Q42875598-9DEBD41B-DE5A-409C-BDF2-61660D7E8607Q43174614-A32701D2-EEA3-47DF-982D-EA8F6A1AC6E0Q51651770-0CE0141E-DAEE-463D-A21F-4F8A1A1A4E81Q52654595-024B1F16-E995-46EC-B7B7-F0625FDF5B6C
P2860
A novel two-step procedure to expand cardiac Sca-1+ cells clonally.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
A novel two-step procedure to expand cardiac Sca-1+ cells clonally.
@ast
A novel two-step procedure to expand cardiac Sca-1+ cells clonally.
@en
type
label
A novel two-step procedure to expand cardiac Sca-1+ cells clonally.
@ast
A novel two-step procedure to expand cardiac Sca-1+ cells clonally.
@en
prefLabel
A novel two-step procedure to expand cardiac Sca-1+ cells clonally.
@ast
A novel two-step procedure to expand cardiac Sca-1+ cells clonally.
@en
P2093
P2860
P1476
A novel two-step procedure to expand cardiac Sca-1+ cells clonally
@en
P2093
Keping Qian
Leping Shen
M Ian Phillips
P2860
P304
P356
10.1016/J.BBRC.2007.05.216
P407
P577
2007-06-11T00:00:00Z